• Cardiology, Diabetes & Nephrology
    • Cardiology, Diabetes & Nephrology – London
    • Cardiology, Diabetes & Nephrology – Brazil
    • Cardiology, Diabetes & Nephrology – Canada
    • Cardiology, Diabetes & Nephrology – USA
    • Hatter Horizon Series
    • The 18th Malvern Diabetic Foot Conference
    • Previous Events
      • CDNATL 2019 – London
      • CDNATL 2019 – Brazil
      • CDNATL 2018
      • CDNATL 2017
      • CDNATL 2016
      • CDNATL 2015
      • CDNATL 2014
      • CDATL 2013
      • CDATL 2012
      • NATL 2012
      • CDATL 2011
      • CDATL 2010
      • NATL 2010
      • CATL 2009
      • NATL 2009
  • Cell Therapy
    • Cell Therapy at the Limits 2021
  • Oncology
    • Previous Events
      • Accelerating Cancer Immunotherapy 2017
      • OATL 2016
      • OATL 2015
      • OATL 2014
      • OATL 2012
      • OATL 2011
      • OATL 2010
      • UCL Frontiers of Oncology 2019
        • Haematology
        • Melanoma
        • Urology
        • Women’s Health
        • Lung Cancer
        • Gastrointestinal Oncology
  • Multiple Sclerosis
    • Multiple Sclerosis at the Limits 2021
    • Multiple Sclerosis Nurses at the Limits 2021
    • Previous events
      • Multiple Sclerosis at the Limits 2020
      • Multiple Sclerosis Nurses at the Limits 2020
      • Multiple Sclerosis Nurses at the Limits 2019
      • MSATL 2018: Introduction
      • MSATL 2017: Introduction
  • About
    • Academic Founders
    • Independence
    • The Lancet
    • Support & Sponsorship
    • Delegate Invitations
  • Supporters
  • Archive
    • CDNATL 2019 – London
    • CDNATL 2019 – Brazil
    • Multiple Sclerosis at the Limits 2018
    • Multiple Sclerosis at the Limits 2020
    • Multiple Sclerosis Nurses at the Limits 2020
    • Multiple Sclerosis Nurses at the Limits 2019
    • Hatter Horizon Series
      • Horizon GP Programme 2019
      • Hatter Horizon Series 2019
      • Hatter Horizon Series 2018
      • Hatter Horizon Series 2017
    • Cardiology, Diabetes & Nephrology at the Limits 2018
    • Accelerating Cancer Immunotherapy 2017
    • Oncology at the Limits 2017

Professor Keith Fox

Professor Keith Fox, BSc (hons) MBChB, FRCP, FESC, FACC, FMedSci: the British Heart Foundation and the Duke of Edinburgh Professor of Cardiology of the University of Edinburgh

He was a founding fellow of the European Society of Cardiology and Chair of the Programme of the European Society of Cardiology 2012-2014.  In addition, he was President of the British Cardiovascular Society from 2009 to 2012.  Professor Fox gave the State-of-the-Art Lecture on Acute Coronary Syndromes at the American Heart Association as well as the Lord Rayner Lecture of the Royal College of Physicians (London) and the Sir Stanley Davidson Lecture of the Royal College (Edinburgh) the Michael Davies Memorial Lecture (London) 09-12-13. His awards include the Silver Medal of the European Society of Cardiology in 2010 and again in 2014 and the Mackenzie medal of the British Cardiovascular Society (2013). He gave the American Heart Association “Paul Dudley White Lecture” at the AHA Congress in 2015. He was awarded the Gold Medal of the ESC in 2015.

Professor Fox’s major research interest lies in the mechanisms and manifestations of acute coronary arterial disease; his work extends from underlying biological mechanisms to in vitro and in vivo studies and clinical trials.  He is the author of more than 680 scientific papers (H index Web of Science/Scopus 106, Citations: 63,850 to June 2017).

Professor Fox has led national and international trials and registries in the field of ACS and thrombosis. He is co-chairman of ROCKET-AF, PIONEER, COMPASS and OASIS programme and chair of the RITA BHF study and GRACE programme (the largest multinational study in acute coronary syndromes), and a lead investigator for studies on novel anti-thrombins, anti-coagulants and antiplatelets.

He is an International Associate Editor of the European Heart Journal and served as Deputy Editor of the Journal of the American College of Cardiology JACC (Europe).  His ongoing research interests include the mechanisms of inflammation and plaque rupture in acute coronary syndromes and antithrombotic therapies. He has been honoured by the American College of Cardiology as one of four “Legends in Cardiology” in 2015 and also by the European Society of Cardiology in 2015.

Winner (with two colleagues) of the Queen’s Anniversary Prize (for Science and Medicine 2016).

Thompson Reuters 2014 and 2015: Professor Keith Fox is listed as one of the top 1% of scientists “the World’s Most Influential Scientific Minds”.

« Professor Martin Cowie
Dr Walter Willett »

The 18th Malvern Diabetic Foot Conference
Wednesday, 7 – Friday, 9 July 2021, Malvern, UK

Multiple Sclerosis Nurses
at the Limits

Friday, 10 & Saturday, 11 September 2021, London, UK

Multiple Sclerosis at the Limits
Monday, 13 & Tuesday, 14 September 2021, London, UK

Hatter Horizon GP Meeting
Monday, 1 November 2021
London, UK

Cell Therapy at the Limits 2021
Monday, 8 & Tuesday, 9 November 2021, London, UK

Hatter Horizon Series
Monday, 22 November 2021, London, UK

Cardiology, Diabetes & Nephrology at the Limits Brazil
Friday, 10 - Saturday, 11 December 2021, São Paulo, Brazil

Cardiology, Diabetes & Nephrology at the Limits 2022
Monday, 4 & Tuesday, 5 April 2022, London,UK

Cardiology, Diabetes & Nephrology at the Limits Canada
Tuesday, 24 & Wednesday, 25 May 2022, Toronto, Canada

Policy links

  • Medical Disclaimer
  • Disclosure
  • E-mail Policy
  • Privacy Policy
  • Anti-spam Policy
  • Disclaimer
  • External Links Policy
  • Terms of use
  • Contact
  • The Lancet
  • UCL
  • UCT
  • Brigham & Women’s Hospital
  • The University of Campinas
© 2021 At the Limits Ltd.
This site uses cookies More info